MedPath

Monitoring Subjects With Fluid-Management Issues In the Home Environment

Completed
Conditions
Hypertension
Heart Failure
Registration Number
NCT02190877
Lead Sponsor
Baxter Healthcare Corporation
Brief Summary

This study is designed to validate ease-of-use for the CoVa Monitoring System, along with simple statistical parameters such as reproducibility and inter-subject agreement between test and reference devices.

Detailed Description

The study has the following objectives:

Objective 1: investigate ease-of-use associated with the CoVa Monitoring System: determine if subjects could use the test device on a daily basis, and if the components of this system (Sensor, Gateway, Web-based System) were indeed operational

Objective 2: determine if daily application of the Sensor's adhesive Electrodes resulted in any skin irritation

Objective 3: determine that the long-term reproducibility of measurements made by the test device is as good or better than the long-term reproducibility of the reference device

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Subject is between 21 (twenty-one) and 90 (ninety) years of age at screening.
  • Subject will have a current prescription for a diuretic medication.
  • Subject and/or legally authorized person/representative is willing to undergo the Informed Consent process prior to enrollment in the study.
  • Subject is a candidate for this study based on the PI's opinion and knowledge of the subject's condition.
Exclusion Criteria
  • Subject is participating in another clinical study that may affect the results of either study.
  • Subject is unable or not willing to wear electrode patches as required.
  • Subject has skin sensitivity to adhesive or hydrogel materials used in electrode patches.
  • Subject has a pacemaker, implanted cardioverter-defibrillator, or ventricular assist device.
  • Subject is considered by the PI to be medically unsuitable for study participation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ease of UseEach subject will be measured once per weekday over a 6 week period

Investigate ease of use associated with the CoVa Monitoring System: determine if subjects could use the test device on a daily basis, and if the components of this system (Sensor, Gateway, Web-based System) were indeed operational

Secondary Outcome Measures
NameTimeMethod
SKin irritation and reproducibilityEach subject will be measured once per weekday over a 6 week period

Determine if subjects had skin irritation from daily use for 30 days. Determine the long-term reproducibility of the measurements from the test device versus the reference device

Trial Locations

Locations (1)

Riverside Meadows

🇺🇸

Riverside, California, United States

© Copyright 2025. All Rights Reserved by MedPath